Antti Rannikko Selected Research

Antti Rannikko Research Topics

Disease

46	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 01/2004
16	Neoplasms (Cancer) 01/2023 - 12/2003
5	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2021
4	Disease Progression 07/2018 - 12/2011
2	Diabetic Nephropathies (Diabetic Nephropathy) 05/2023 - 01/2023
2	Carcinogenesis 07/2018 - 12/2003
1	Fatigue 02/2024
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2023
1	Erectile Dysfunction 02/2023
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 01/2022
1	Hyperinsulinism (Hyperinsulinemia) 12/2021
1	Necrosis 01/2020
1	Adenosquamous Carcinoma 01/2018
1	Adenocarcinoma 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2015
1	Breast Neoplasms (Breast Cancer) 09/2011
1	Hypogonadism (Hypergonadotropic Hypogonadism) 07/2006
1	Hemorrhage 11/2004
1	Seminoma 12/2003
1	Testicular Neoplasms (Testicular Cancer) 12/2003
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 12/2003
1	Teratocarcinoma 12/2003

Drug/Important Bio-Agent (IBA)

10	Prostate-Specific Antigen (Semenogelase)IBA 01/2024 - 01/2009
8	Biomarkers (Surrogate Marker)IBA 05/2023 - 12/2011
8	AndrogensIBA 01/2023 - 12/2003
7	Messenger RNA (mRNA)IBA 05/2023 - 12/2003
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2023 - 12/2011
5	Kallikreins (Kallikrein)IBA 01/2023 - 01/2017
4	Androgen Receptors (Androgen Receptor)IBA 02/2024 - 12/2003
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2003
2	Leuprolide (Lupron)FDA LinkGeneric 12/2023 - 10/2023
2	enzalutamideIBA 12/2023 - 10/2023
2	Peptide Hydrolases (Proteases)FDA Link 01/2023 - 01/2023
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2022
2	CytokinesIBA 01/2022 - 01/2020
2	VaccinesIBA 10/2021 - 01/2021
2	Phytoestrogens (Phytoestrogen)IBA 07/2006 - 01/2006
1	darolutamideIBA 02/2024
1	Phenobarbital (Luminal)FDA Link 09/2023
1	protein phosphatase methylesterase-1IBA 06/2023
1	Serine Proteases (Serine Protease)IBA 01/2023
1	Proteinase-Activated ReceptorsIBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	EnzymesIBA 01/2023
1	matriptaseIBA 01/2023
1	CholesterolIBA 01/2022
1	Atorvastatin (Lipitor)FDA Link 01/2022
1	Interleukin-7 (Interleukin 7)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2021
1	Insulin (Novolin)FDA Link 12/2021
1	Metformin (Glucophage)FDA LinkGeneric 12/2021
1	LigandsIBA 10/2021
1	Peptides (Polypeptides)IBA 10/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2021
1	EpitopesIBA 01/2021
1	CD40 Ligand (CD40L)IBA 01/2021
1	Granzymes (Granzyme)IBA 01/2020
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 10/2019
1	STAT5 Transcription FactorIBA 10/2019
1	AldosteroneIBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	ReninIBA 01/2019
1	AngiotensinsIBA 01/2019
1	Heat Shock Transcription FactorsIBA 07/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Caveolin 1IBA 01/2018
1	navitoclaxIBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 01/2017
1	Calcibiotic Root Canal SealerIBA 01/2017
1	LipidsIBA 12/2011
1	Phospholipases (Phospholipase)IBA 12/2011
1	Antineoplastic Agents (Antineoplastics)IBA 12/2011
1	ChromatinIBA 09/2011
1	SolutionsIBA 04/2010
1	Tranexamic Acid (AMCA)FDA Link 11/2004
1	Finasteride (Propecia)FDA LinkGeneric 01/2004
1	SteroidsIBA 12/2003
1	Estrogen Receptor betaIBA 12/2003
1	Estrogens (Estrogen)FDA Link 12/2003
1	ParaffinIBA 12/2003
1	Steroid Receptors (Steroid Receptor)IBA 12/2003

Therapy/Procedure

17	Prostatectomy (Retropubic Prostatectomy) 02/2023 - 01/2011
16	Therapeutics 03/2024 - 01/2009
5	Castration 02/2024 - 01/2017
2	Radiotherapy 03/2024 - 07/2022
1	Conservative Treatment 03/2024
1	Immunotherapy 01/2020
1	Precision Medicine 10/2019
1	Organ Transplantation 06/2006
1	Transurethral Resection of Prostate (TURP) 11/2004